DavidNAlexanderMD
Neurology • Los Angeles, CANeurorehabilitation, Vascular Neurology
Professor Emeritus, Department of Neurology, Geffen School of Medicine at UCLA Inaugural Susan and David Wilstein Endowed Chair in Rehabilitation Medicine 2016-2021 & Inaugural Medical Director, California Rehabilitation Institute, 2015-2020
Dr. Alexander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Reed Neurological Research Center
710 Westwood Plaza, C-239
Los Angeles, CA 90095Phone+1 310-825-2400Fax+1 310-825-2400- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1981 - 1983
Boston University Medical CenterInternship, Internal Medicine, 1979 - 1980
University of Minnesota Medical SchoolClass of 1979
Amherst CollegeBA, Neuroscience, 1975
Certifications & Licensure
NY State Medical License 1981 - Present
CA State Medical License 1983 - 2024- American Board of Physical Medicine and Rehabilitation Spinal Cord Injury Medicine
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- Best Doctors in America 2009-2015
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 3 citationsDextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial.Richard D. Zorowitz, David N. Alexander, Andrea E. Formella, Fred Ledon, Charles S. Davis, Joao Siffert> ;PM & R. 2019 Jan 1
- 4 citationsErratum to: PRISM II: An open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic ...Flora M. Hammond, David N. Alexander, Andrew J. Cutler, Stephen D'Amico, Rachelle S. Doody, William Sauve, Richard D. Zorowitz, Charles S. Davis, Paul Shin, Fred Ledon...> ;BMC Neurology. 2016 Sep 2
- 10 citationsPRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.Flora M Hammond, David N Alexander, Andrew J Cutler, Stephen D'Amico, Rachelle S Doody, William Sauve, Richard D Zorowitz, Charles S Davis, Paul Shin, Fred Ledon, Char...> ;BMC Neurology. 2016 Jun 9
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California- California Rehabilitation InstituteLos Angeles, California
- UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
